Stimwave Begins Marketing StimQ Peripheral Nerve Stimulator

Stimwave has begun to market its StimQ peripheral nerve stimulator for the treatment of severe intractable chronic pain of peripheral origin.

The device received FDA clearance earlier this month and is the first wireless, fully programmable PNS neuromodulation device on the market, the company says.

The company aims to reduce cost of care and offer an alternative to surgery or ongoing opioid treatment. — Anisa Jibrell